124 results
8-K
EX-10.1
LQDA
Liquidia Corp
14 May 24
Departure of Directors or Certain Officers
4:30pm
group long-term disability plan in which the Employee participates that is maintained by the Company or the Employee’s Employer and in effect
8-K
EX-99.1
LQDA
Liquidia Corp
13 May 24
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
6:24pm
of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements
8-K
EX-99.1
nmtltkrn1jspkybrr
1 Apr 24
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
7:00am
S-8
a302j5ciyq1fi
13 Mar 24
Registration of securities for employees
4:34pm
S-8
EX-5.1
f0xxxeelar8111zf
13 Mar 24
Registration of securities for employees
4:34pm
S-8
2oljp0 3cx5sale6
13 Mar 24
Registration of securities for employees
4:34pm
8-K
EX-99.1
dv4ae0en8 3hrww
13 Mar 24
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
6:14am
8-K
EX-99.1
s721ctt1d8
25 Jan 24
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
7:01am
8-K
j09m4tvps353jpj2f4
19 Jan 24
Liquidia Corporation Announces Updates to Operations Leadership
7:01am